AAAAAA
Results:
1-20
|
Results: 20
Authors:
RZANY B
JUNG M
PARTSCHT K
DIEDERICH R
BUCHNER L
MECKING D
KAISER HW
MEURER M
MESSER G
Citation: B. Rzany et al., MOLECULAR EPIDEMIOLOGY OF BULLOUS PEMPHIGOID, Journal of investigative dermatology, 110(4), 1998, pp. 515-515
Authors:
RZANY B
JUNG M
PARTSCHT K
BUCHNER L
MECKING D
KAISER HW
MEURER M
MESSER G
Citation: B. Rzany et al., RISK-FACTORS FOR REPEATED HOSPITALIZATION AND DEATH IN PATIENTS WITH BULLOUS PEMPHIGOID (BP) - FIRST RESULTS OF A MULTICENTER SURVIVAL ANALYSIS, Journal of investigative dermatology, 110(2), 1998, pp. 4-4
Authors:
RZANY B
NALDI L
SCHAFER T
STERN R
WILLIAMS H
Citation: B. Rzany et al., THE DIAGNOSIS OF PSORIASIS - DIAGNOSTIC-CRITERIA, British journal of dermatology, 138(5), 1998, pp. 917-917
Authors:
RZANY B
MOCKENHAUPT M
SCHLINGMANN J
RAMISCH S
MESSER G
SCHOPF E
Citation: B. Rzany et al., GENETIC ANALYSES IN PATIENTS WITH SEVERE SKIN REACTIONS - NO ASSOCIATION OF THE TNF-ALPHA-308 BP PROMOTER ENHANCER POINT MUTATION AND TNF-BETA/LYMPHOTOXIN-ALPHA NCOI POLYMORPHISM/, Journal of investigative dermatology, 108(3), 1997, pp. 30-30
Authors:
HERING O
MOCKENHAUPT M
RZANY B
SCHRODER W
SCHOPF E
Citation: O. Hering et al., THE DERMAL TYPE OF ERYTHEMA MULTIFORME - A RARE VARIANT OF STEVENS-JOHNSON-SYNDROME OR CASES OF CLINICAL MISCLASSIFICATION, Acta dermato-venereologica, 77(3), 1997, pp. 217-218
Authors:
RZANY B
MOCKENHAUPT M
BAUR S
SCHRODER W
STOCKER U
MUELLER J
HOLLANDER N
BRUPPACHER R
SCHOPF E
Citation: B. Rzany et al., EPIDEMIOLOGY OF ERYTHEMA EXSUDATIVUM MULTIFORME MAJUS, STEVENS-JOHNSON SYNDROME, AND TOXIC EPIDERMAL NECROLYSIS IN GERMANY (1990-1992) - STRUCTURE AND RESULTS OF A POPULATION-BASED REGISTRY, Journal of clinical epidemiology, 49(7), 1996, pp. 769-773
Authors:
RZANY B
HERING O
MOCKENHAUPT M
SCHRODER W
GOERTTLER E
RING J
SCHOPF E
Citation: B. Rzany et al., HISTOPATHOLOGICAL AND EPIDEMIOLOGIC CHARACTERISTICS OF PATIENTS WITH ERYTHEMA EXUDATIVUM MULTIFORME MAJOR, STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS, British journal of dermatology, 135(1), 1996, pp. 6-11
Authors:
RZANY B
CORESH J
PETRI M
Citation: B. Rzany et al., RISK-FACTORS FOR HYPERCREATINEMIA IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - LATER RHEUMATOLOGICAL REFERRAL INCREASES RISK, Arthritis and rheumatism, 39(9), 1996, pp. 1649-1649
Authors:
KELLY JP
AUQUIER A
RZANY B
NALDI L
BASTUJIGARIN S
CORREIA O
SHAPIRO S
KAUFMAN DW
Citation: Jp. Kelly et al., AN INTERNATIONAL COLLABORATIVE CASE-CONTROL STUDY OF SEVERE CUTANEOUSADVERSE REACTIONS (SCAR) - DESIGN AND METHODS, Journal of clinical epidemiology, 48(9), 1995, pp. 1099-1108
Authors:
ROUJEAU JC
KELLY JP
NALDI L
RZANY B
STERN RS
ANDERSON T
AUQUIER A
BASTUJIGARIN S
CORREIA O
LOCATI F
MOCKENHAUPT M
PAOLETTI C
SHAPIRO S
SHEAR N
SCHOPF E
KAUFMAN DW
Citation: Jc. Roujeau et al., MEDICATION USE AND THE RISK OF STEVENS-JOHNSON SYNDROME OR TOXIC EPIDERMAL NECROLYSIS, The New England journal of medicine, 333(24), 1995, pp. 1600-1607
Authors:
MOCKENHAUPT M
RZANY B
SCHRODER W
HOLLANDER N
SCHOPF E
Citation: M. Mockenhaupt et al., DRUG RISK FOR STEVENS-JOHNSON SYNDROME (SJS) AND TOXIC EPIDERMAL NECROLYSIS (TEN) - EVALUATION OF ANTIEPILEPTICS BASED ON SALE NUMBERS IN DEFINED DAILY DOSES (DDD), Journal of investigative dermatology, 104(4), 1995, pp. 620-620
Authors:
SCHOPF E
RZANY B
SCHRODER W
HOCHSTETTER R
MOCKENHAUPT M
Citation: E. Schopf et al., STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS - EPIDEMIOLOGY AND DRUG ATTRIBUTIBILITY, Journal of investigative dermatology, 104(4), 1995, pp. 620-620
Authors:
RZANY B
MOCKENHAUPT M
SCHRODER W
HOCHSTETTER R
SCHOPF E
Citation: B. Rzany et al., STEVENS-JOHNSON SYNDROME (SJS) AND TOXIC EPIDERMAL NECROLYSIS (TEN) IN THE ELDERLY, Journal of investigative dermatology, 104(4), 1995, pp. 620-620
Authors:
RZANY B
MOCKENHAUPT M
SCHOPF E
Citation: B. Rzany et al., DRUG-INDUCED SEVERE SKIN REACTIONS - DIAG NOSIS, EPIDEMIOLOGY AND THERAPY OF TOXIC EPIDERMAL NECROLYSIS AND STEVENS-JOHNSON SYNDROME, Allergologie, 17(10), 1994, pp. 463-466
Authors:
RZANY B
MOCKENHAUPT M
GEHRING W
SCHOPF E
Citation: B. Rzany et al., STEVENS-JOHNSON SYNDROME AFTER TERBINAFINE THERAPY, Journal of the American Academy of Dermatology, 30(3), 1994, pp. 509-509
Authors:
BAUR S
RZANY B
MOCKENHAUPT M
HOLLANDER N
STOCKER U
MUELLER J
SCHRODER W
SCHOPF E
Citation: S. Baur et al., INCIDENCE OF STEVENS-JOHNSON-SYNDROME (SJS) AND TOXIC EPIDERMAL NECROLYSIS (TEN) IN WEST-GERMANY AND BERLIN AMONG DIFFERENT ETHNIC-GROUPS, Journal of investigative dermatology, 102(4), 1994, pp. 619-619
Authors:
RZANY B
MOCKENHAUPT M
HOLLANDER N
ZOBEL K
STOCKER U
SCHRODER W
MUELLER J
BAUR S
SCHOPF E
Citation: B. Rzany et al., VERY LOW-RISK FOR ACE-INHIBITORS ASSOCIATED WITH STEVENS-JOHNSON-SYNDROME (SJS) AND TOXIC EPIDERMAL NECROLYSIS (TEN) BASED ON PRESCRIPTION DATA IN DEFINED DAILY DOSES (DDD), Journal of investigative dermatology, 102(4), 1994, pp. 619-619
Authors:
MOCKENHAUPT M
SCHUPP P
RZANY B
STOCKER U
MUELLER J
SCHRODER W
BAUR S
SCHOPF E
Citation: M. Mockenhaupt et al., SERIOUS CUTANEOUS ADVERSE REACTIONS - DIFFERENCES IN DEMOGRAPHY AND PAST HISTORY OF DRUG INTAKE BETWEEN STEVENS-JOHNSON-SYNDROME (SJS) TOXIC EPIDERMAL NECROLYSIS (TEN) AND GENERALIZED BULLOUS FIXED DRUG ERUPTION (GBFDE), Journal of investigative dermatology, 102(4), 1994, pp. 619-619
Authors:
RZANY B
MOCKENHAUPT M
BAUR S
STOCKER U
SCHOPF E
Citation: B. Rzany et al., SEVERE CUTANEOUS REACTIONS - TOXIC EPIDER MAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, ERYTHEMA-EXSUDATIVUM MULTIFORME-MAJUS AND GENERALIZED BULLOUS FIXED DRUG ERUPTION, Hautarzt, 44(8), 1993, pp. 549-556
Authors:
RZANY B
MOCKENHAUPT M
STOCKER U
HAMOUDA O
SCHOPF E
Citation: B. Rzany et al., INCIDENCE OF STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN GERMANY, Archives of dermatology, 129(8), 1993, pp. 1059-1059
Risultati:
1-20
|